US Cetirizine Dihydrochloride Prices Extends July Gains on Seasonal Allergy Demand

US Cetirizine Dihydrochloride prices remained firm in July 2026, extending the modest upward trend observed in previous months. Strong seasonal allergy demand, driven by severe grass pollen exposure across key US regions and elevated outdoor allergen levels, continued to support robust consumption of Cetirizine Dihydrochloride-based antihistamine products. Pharmaceutical manufacturers maintained steady procurement activity, while retail and institutional demand remained healthy. The US market continued to rely heavily on imported Cetirizine Dihydrochloride from India and China, where supply availability remained stable. However, elevated transpacific freight costs, peak-season surcharges, and occasional port congestion increased landed costs and supported firm CFR Houston pricing. Upstream feedstock costs, including acetonitrile and toluene, also provided moderate cost support. For the remainder of July, Cetirizine Dihydrochloride prices are expected to remain stable-to-firm. Continued allergy-related demand and ongoing logistics costs are likely to sustain market support, while adequate inventories and stable import availability should limit excessive price volatility. Overall, Cetirizine Dihydrochloride is expected to maintain a modest upward trend in the near term.